ADGRE5 and melanoma: For example, a tissue-specific knockout of medaka adgre5 could cause even more malignant melanoma phenotypes, in analogy to the knockout of cdkn2ab which resulted in strongly enhanced tumor growth (Regneri et al. 2019).